The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.i

Subclinical pulmonary infiltrates/ILD

Publications

Venkatramani R, Kamath S, Wong K, Olch AJ, Malvar J, Sposto R, Goodarzian F, Freyer DR, Keens TG, Mascarenhas L

Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation.

Pediatric blood & cancer 2014 Jul;61;1277-81 — 2014 Jul — 1277-81

Aviram G, Yu E, Tai P, Lefcoe MS

Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2001 Dec;52;385-91 — 2001 Dec — 385-91